News

Amgen Inc. closed 13.40% below its 52-week high of $346.85, which the company achieved on July 25th.
From Amgen's classic double-bottom base in February 1990 until it ultimately topped in the summer of 2000, it increased more ...
A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...
A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...
Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.
The idea for Amgen’s first foray into documentary film started with two numbers, according to Nerissa Gomes, general manager ...
Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...
Eric Groen will serve as legal chief, compliance chief and head of business development for Genelux Corp., which is led by a ...
In the last year, many Amgen Inc. (NASDAQ:AMGN) insiders sold a substantial stake in the company which may have sparked ...
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 30, Amgen Inc.
Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...
In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...